CARAVITA, Sergio
 Distribuzione geografica
Continente #
EU - Europa 7.265
NA - Nord America 4.802
AS - Asia 3.098
SA - Sud America 656
Continente sconosciuto - Info sul continente non disponibili 404
AF - Africa 164
OC - Oceania 4
Totale 16.393
Nazione #
US - Stati Uniti d'America 4.572
IE - Irlanda 2.895
SG - Singapore 1.507
RU - Federazione Russa 1.297
GB - Regno Unito 1.000
CN - Cina 673
NL - Olanda 641
IT - Italia 576
BR - Brasile 503
FR - Francia 407
VN - Vietnam 379
CA - Canada 133
DE - Germania 117
ZA - Sudafrica 112
SE - Svezia 107
FI - Finlandia 100
HK - Hong Kong 96
ID - Indonesia 77
BD - Bangladesh 67
IN - India 65
AR - Argentina 59
KR - Corea 41
MX - Messico 37
PL - Polonia 34
EC - Ecuador 26
TR - Turchia 26
IQ - Iraq 25
AT - Austria 21
JP - Giappone 20
CO - Colombia 19
PK - Pakistan 17
MY - Malesia 16
ES - Italia 14
JM - Giamaica 14
UA - Ucraina 13
VE - Venezuela 12
EG - Egitto 11
PY - Paraguay 11
SA - Arabia Saudita 11
PE - Perù 10
PH - Filippine 10
UZ - Uzbekistan 10
ET - Etiopia 9
MA - Marocco 9
NP - Nepal 9
CR - Costa Rica 8
TT - Trinidad e Tobago 8
CL - Cile 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
BG - Bulgaria 6
HN - Honduras 6
KE - Kenya 6
LT - Lituania 6
EU - Europa 5
IR - Iran 5
LB - Libano 5
UY - Uruguay 5
AU - Australia 4
BO - Bolivia 4
KG - Kirghizistan 4
MD - Moldavia 4
SV - El Salvador 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
MN - Mongolia 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
RO - Romania 3
AL - Albania 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IL - Israele 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
Totale 15.982
Città #
Dublin 2.865
Southend 840
San Jose 765
Council Bluffs 705
Ashburn 643
Singapore 626
Moscow 453
Hefei 208
Princeton 174
Ho Chi Minh City 134
New York 128
Santa Clara 123
Los Angeles 117
Lauterbourg 108
Boardman 103
Johannesburg 101
Chandler 90
Hanoi 90
Columbus 87
Hong Kong 87
Milan 86
The Dalles 86
Beijing 84
Altamura 70
Helsinki 68
Washington 62
Toronto 61
Buffalo 50
São Paulo 47
Fairfield 46
Wilmington 46
Jakarta 45
Dallas 41
Frankfurt am Main 41
Redondo Beach 41
Chicago 35
Dalmine 35
London 33
Seoul 31
Guangzhou 30
Phoenix 30
Ogden 27
Da Nang 25
Lappeenranta 25
Montreal 25
Shanghai 25
Rome 24
Munich 22
Nuremberg 20
Amsterdam 19
Atlanta 19
Bergamo 19
Rio de Janeiro 19
Shenzhen 19
Denver 18
Orem 18
Reggio Calabria 18
Boston 17
Brooklyn 17
Tokyo 17
Mexico City 16
Houston 15
San Diego 15
San Francisco 15
Pune 14
Baghdad 13
Norwalk 13
Eygelshoven 12
Warsaw 12
Woodbridge 12
Ankara 11
Curitiba 11
Hangzhou 11
Naples 11
Seattle 11
Tianjin 11
Andover 10
Biên Hòa 10
Bologna 10
Brasília 10
Chennai 10
Dhaka 10
Guayaquil 10
Haiphong 10
Poplar 10
Ribeirão Preto 10
Salt Lake City 10
The Bronx 10
Addis Ababa 9
Boydton 9
Cambridge 9
Kingston 9
Lima 9
Manchester 9
Palermo 9
Stockholm 9
Tashkent 9
Vienna 9
Assago 8
Erbil 8
Totale 10.337
Nome #
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 251
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 223
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 212
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 196
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 193
Blood pressure at high altitude: Physiology and clinical implications 192
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 190
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 189
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 186
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 184
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 182
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 181
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 181
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 179
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 178
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 175
Blood pressure and high altitude: physiological response and clinical management 174
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 172
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 171
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 171
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 170
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 168
Right ventricular reserve in cardiopulmonary disease: a simultaneous hemodynamic and three-dimensional echocardiographic study 167
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 167
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 165
Discrepancy in the Diagnosis of Heart Failure With Preserved Ejection Fraction Between Supine Versus Upright Exercise Hemodynamic Testing 165
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 163
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 163
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 163
Impact of COVID-19 lockdown on exercise capacity in PAH patients 160
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 160
Interatrial Shunt Devices 159
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 159
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 157
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 157
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 155
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 155
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 155
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 155
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 154
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 154
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 153
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 152
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 151
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 150
Hyperparathyroidism in celiac disease: always secondary? 149
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 147
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 147
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 146
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 146
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 145
CPET for Long COVID-19 143
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 143
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 143
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 142
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 142
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 141
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 140
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 140
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 138
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 138
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 137
Pulmonary arterial hypertension 137
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 137
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 136
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 135
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 135
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 134
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 134
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 133
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 133
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 133
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 133
Recent advances in multimodality imaging of the tricuspid valve 133
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 130
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 130
Phenotyping long COVID 129
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 128
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 128
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 128
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 127
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 127
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 127
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 126
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 125
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 125
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 123
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 123
Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation 122
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 120
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 119
Heart failure and anemia: Effects on prognostic variables 116
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 116
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 115
Gestione clinico-strumentale e della terapia anticoagulante nel follow-up del paziente con embolia polmonare: i risultati della survey “FOLLOW-EP” promossa dall’Area Malattie del Circolo Polmonare ANMCO = Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: The results of the "FOLLOW-EP" survey promoted by the ANMCO Pulmonary Circulation Diseases Area 112
Why Do Exercise Hemodynamics Matter? 112
Invasive haemodynamic assessment in heart failure with preserved ejection fraction 111
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 110
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 107
Pulmonary Hypertension Associated with Left Heart Disease 105
Totale 14.938
Categoria #
all - tutte 79.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022841 0 0 0 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/20252.975 102 248 85 356 99 32 29 122 363 796 400 343
2025/20266.154 224 324 564 867 771 455 773 386 516 464 593 217
2026/20271.385 270 272 435 408 0 0 0 0 0 0 0 0
Totale 16.393